These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effect of ACE inhibitors on the atrial natriuretic peptides in heart failure. Struthers AD Br Heart J; 1994 Dec; 72(6):504. PubMed ID: 7857729 [No Abstract] [Full Text] [Related]
6. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Cheung B Br Heart J; 1995 Jun; 73(6):584-5. PubMed ID: 7626365 [No Abstract] [Full Text] [Related]
7. Prospects for using a blood sample in the diagnosis of heart failure. Struthers AD QJM; 1995 May; 88(5):303-6. PubMed ID: 7796082 [No Abstract] [Full Text] [Related]
8. [Human atrial natriuretic peptide (hANP), human brain natriuretic peptide (hBNP)]. Tsujino M; Hirata Y Nihon Rinsho; 1995 Mar; 53 Su Pt 2():737-40. PubMed ID: 8753347 [No Abstract] [Full Text] [Related]
9. Influence of candoxatril on plasma brain natriuretic peptide in heart failure. Lang CC; Motwani J; Coutie WJ; Struthers AD Lancet; 1991 Jul; 338(8761):255. PubMed ID: 1676808 [No Abstract] [Full Text] [Related]
10. Diagnosis of symptomless left ventricular dysfunction. Barnett DB Lancet; 1993 May; 341(8853):1124-5. PubMed ID: 8097808 [No Abstract] [Full Text] [Related]
11. Effect of the maze procedure for atrial fibrillation on atrial and brain natriuretic peptide. Nakamura M; Niinuma H; Chiba M; Ueshima K; Arakawa N; Yagi Y; Kawazoe K; Hiramori K Am J Cardiol; 1997 Apr; 79(7):966-70. PubMed ID: 9104915 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Fischer Y; Filzmaier K; Stiegler H; Graf J; Fuhs S; Franke A; Janssens U; Gressner AM Clin Chem; 2001 Mar; 47(3):591-4. PubMed ID: 11238315 [No Abstract] [Full Text] [Related]
13. Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP. Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Boomsma F; van Veldhuisen DJ Eur J Heart Fail; 2005 Jan; 7(1):81-6. PubMed ID: 15642536 [TBL] [Abstract][Full Text] [Related]
15. Assessment of heart failure with plasma natriuretic peptides. Underwood M Lancet; 1998 Feb; 351(9100):444-5; author reply 445. PubMed ID: 9482329 [No Abstract] [Full Text] [Related]
16. [New clinical tests in diagnosis of cardiovascular system diseases]. Nagai R Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):507-11. PubMed ID: 8340660 [No Abstract] [Full Text] [Related]
17. Concentrations of brain natriuretic peptide in treated congestive heart failure. Togashi K; Ando K; Hasegawa N; Kawakami M; Marumo F Clin Chem; 1991 May; 37(5):765. PubMed ID: 1827759 [No Abstract] [Full Text] [Related]
18. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Lang CC; Prasad N; McAlpine HM; Macleod C; Lipworth BJ; MacDonald TM; Struthers AD Am Heart J; 1994 Jun; 127(6):1635-6. PubMed ID: 8197998 [No Abstract] [Full Text] [Related]
19. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213 [TBL] [Abstract][Full Text] [Related]
20. Brain and atrial natriuretic peptides in patients with ischemic heart disease with and without heart failure. Arad M; Elazar E; Shotan A; Klein R; Rabinowitz B Cardiology; 1996; 87(1):12-7. PubMed ID: 8631038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]